DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical ...
INR:8692. rummy aresa New paper reveals the current status of fecal transplantation for treating various human diseases Faster and safer! FDA approves first COVID-19 ...